2014
DOI: 10.1007/s12032-014-0217-z
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group

Abstract: Non-small cell lung cancer (NSCLC) is one of the most common cancers. Most of the patients are inoperable at the time of diagnosis, and the prognosis is poor. Many prognostic factors have been identified in prior studies. However, it is not clear which factor is more useful. In this study, we investigated whether uric acid, the last breakdown product of purine metabolism in humans, has a prognostic significance in advanced NSCLC. A total of 384 NSCLC patients at stage IIIB/IV and who did not meet exclusion cri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
27
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 27 publications
(29 citation statements)
references
References 27 publications
0
27
2
Order By: Relevance
“…Squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, and large-cell carcinoma are histological sub-groups of NSCLC. [3][4][5] Anatomical, clinical, and sociodemographic characteristics conventionally used as prognostic factors include phase, performance status, gender, age, and histological type. 1,2 The prognosis is generally not good for NSCLC with 80% being inoperable at the time of diagnosis and a 5-year overall survival of approximately 5%-10%.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, and large-cell carcinoma are histological sub-groups of NSCLC. [3][4][5] Anatomical, clinical, and sociodemographic characteristics conventionally used as prognostic factors include phase, performance status, gender, age, and histological type. 1,2 The prognosis is generally not good for NSCLC with 80% being inoperable at the time of diagnosis and a 5-year overall survival of approximately 5%-10%.…”
Section: Introductionmentioning
confidence: 99%
“…These histological types are been grouped together because their prognosis characteristics and treatment approaches are nearly similar. [3][4][5] However, the usefulness of any of these factors as an independent prognostic factor is not yet certain. 1 Previous studies have investigated the effect of clinical, histological, biological, chemical, and genetic characteristics on the prognosis of NSCLC patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…as patient characteristics including weight loss, smoking habits, comorbidities, and ethnicity and tumor features including histological degree, number of metastatic sites, vascular or local invasion, malign pleural effusion, and localization of the primary tumor may be potential prognostic factors in NSCLC.3-5 It is still unknown, however, which one is more useful and independent factor in the prognosis of the disease (Berghmans et al, 2011;Tanriverdi et al, 2014). Currently, certain molecular markers, genetic features, and treatment modalities have been suggested to be possible prognostic factors and have predictive values (Berghmans et al, 2008;Seculier et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, certain molecular markers, genetic features, and treatment modalities have been suggested to be possible prognostic factors and have predictive values (Berghmans et al, 2008;Seculier et al, 2008). In recent years, a number of biomarkers having a prognostic impact have been widely studied in NSCLC (Tanriverdi et al, 2014).…”
Section: Introductionmentioning
confidence: 99%